All studies
Phase not statedRecruitingObservationalNCT06987474

Capella Scientia Development Study

Capella Scientia (SCDX) Development Study

  • Cataract
I want to take partRefer a patient1 site in India · 5 worldwide

At a glance

Phase
Phase not stated
Study type
Observational
Sponsor
Alcon Research
Enrolment target
400
Started
30 July 2025
Main results due (estimated)
May 2027
Study ends (estimated)
May 2027
Observational model
Cohort
Time perspective
Prospective
Sites
5 · 1 in India
First posted
23 May 2025
Registry updated
30 October 2026

Can you take part?

  • Aged 18 years and over.
  • Open to any sex.
  • Who they are looking for: Subjects will be recruited from clinical sites located in India, Spain, and the Philippines.

Age groups: adult, older adult. Sampling: non probability sample.

These are the headline rules. Every study has a longer list, and whether you are eligible is decided by the research team at the site, never by this page.

Read the full eligibility criteria
Inclusion Criteria:

* Able to understand and sign an IRB/IEC approved consent form;
* Willing and able to attend study visit(s) as required by the protocol;
* Consenting age at the jurisdiction of study site;
* Other group-specific, protocol required inclusion criteria may apply.

Exclusion Criteria:

* Women of child-bearing potential;
* Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus);
* Unclear optical media preventing data capture from all devices in the study;
* Contraindicated for pupil dilation (e.g., narrow angles, allergies) per investigator's clinical judgment;
* Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study;
* Other group-specific, protocol required exclusion criteria may apply.

What this study is about

In the sponsor’s own words, from the registry.

This study involves collecting biometry and aberration data using the next generation biometer, Unity DX.

Read the detailed description

In this prospective, noninterventional, single-arm, unmasked, multicenter study, 4 different subject cohorts will be enrolled simultaneously to collect biometry and aberrometry data using Unity DX. This study will be conducted in the US, India, Spain, and the Philippines.

What participants receive

  • Group 1

    Subjects/eyes previously implanted with an Alcon monofocal or multifocal presbyopia correcting IOL. Measurements will be taken with Unity DX and SMARTCataract DX (SCDX) Biometer and either the IOLMaster 700 Biometer or the Argos with Alcon Image Guidance Biometer depending on which device is used at site.

    Device: Unity DX and SMARTCataract DX (SCDX) Biometer · Device: IOLMaster 700 Biometer · Device: Argos with Alcon Image Guidance Biometer

  • Group 2

    Subjects/eyes with planned implantation of an Alcon monofocal or monofocal toric IOL. Measurements will be taken with Unity DX and SMARTCataract DX (SCDX) Biometer and either the IOLMaster 700 Biometer or the Argos with Alcon Image Guidance Biometer depending on which device is used at site.

    Device: Unity DX and SMARTCataract DX (SCDX) Biometer · Device: IOLMaster 700 Biometer · Device: Argos with Alcon Image Guidance Biometer

  • Group 3

    Subjects/eyes with with prior refractive surgery such as LASIK or PRK and planned implantation of an Alcon monofocal or monofocal toric IOL. Measurements will be taken with Unity DX and SMARTCataract DX (SCDX) Biometer and either the IOLMaster 700 Biometer or the Argos with Alcon Image Guidance Biometer depending on which device is used at site.

    Device: Unity DX and SMARTCataract DX (SCDX) Biometer · Device: IOLMaster 700 Biometer · Device: Argos with Alcon Image Guidance Biometer

  • Group 4

    Subjects/eyes with keratoconus, a progressive cornea disorder. Measurements will be taken with Unity DX and SMARTCataract DX (SCDX) Biometer and either the IOLMaster 700 Biometer or the Argos with Alcon Image Guidance Biometer depending on which device is used at site.

    Device: Unity DX and SMARTCataract DX (SCDX) Biometer · Device: IOLMaster 700 Biometer · Device: Argos with Alcon Image Guidance Biometer

Interventions

  • Unity DX and SMARTCataract DX (SCDX) BiometerDevice

    Unity DX is a CE-marked, noninvasive, noncontact instrument that generates a 3D model of the eye using hyper parallel optical coherence tomography (HP OCT), aberrometry, and topography. The current version of SCDX software will be used in this study.

  • IOLMaster 700 BiometerDevice

    The IOLMaster 700 Biometer is a CE-marked, noninvasive, noncontact instrument that captures optical biometry. Data will be collected using standard clinical assessments.

  • Argos with Alcon Image Guidance BiometerDevice

    The Argos with Alcon Image Guidance biometer is a CE-marked, noninvasive, noncontact instrument that will capture optical biometry. Data will be collected using standard clinical assessments.

What the study measures

Primary outcomes

  1. Manifest Refraction Spherical Equivalent (MRSE)

    A manifest refraction (manual refraction) will be performed using a phoropter. The spherical equivalent is calculated by adding the sum of the sphere power with half of the cylinder power. MRSE will be reported in diopters.

    Time frame: Group 1 and Group 4: Day 0; Group 2 and Group 3: Screening (Day -30 to Day -1), Day 30 to 60 postoperative, Day 70 to 100 postoperative

Who is running it

Lead sponsor
Alcon Research
Sponsor type
Industry
Responsible party
The sponsor
Organisation
Alcon Research
Data monitoring committee
No
US FDA-regulated drug
No
US FDA-regulated device
No
Sponsor's study ID
CTK378-E006
  • Principal II, Clinical Trial Operations, Vision Care

    Study director

    Alcon Research, LLC

Study sites(5)

  • Narayana Nethralaya

    Bangalore, India

    Not yet recruiting

  • The Eye Institute of Utah

    Salt Lake City, Utah, United States

    Recruiting

  • Asian Eye Institute

    Makati City, Philippines

    Recruiting

  • Clinica Novovision - Clinica Madrid

    Madrid, Spain

    Recruiting

  • Clinica Rementeria

    Madrid, Spain

    Recruiting

Showing 5 of 5 sites. 4 recruiting, 1 not recruiting and 0 cancelled; 1 in India. Not recruiting covers sites not yet open, finished enrolling, completed or paused; cancelled covers sites withdrawn before opening or stopped for good.

References and data sharing

Participant data shared
No

Source: ClinicalTrials.gov record NCT06987474, status verified October 2026. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Take part

Interested in this study?

Tell us how to reach you and we will connect you with the study team. Or refer someone you care for, with their permission.

A person reads this, not a bot. We are not doctors, this is not medical advice, and it is not for emergencies.

Not the right study?

Every study recruiting in India, one search away.